journal article·2024-09-04

Exploratory Investigation of Zinc-Modified Borosilicate Bioactive Glass: A New Methodology for Its Biocompatibility, Immunoregulation, and Pro-Angiogenic Property Evaluation

Liyan Zhang, Jing Huang, Li Li, Hao Zhang, Shuaijie Li, Wenwen Chai, Xiaochen Chen, Chunyu Liu, John Robert Honiball, Bing Li, Youliang Ren, Lei Chu, Xuegang Luo, Haobo Pan, Xu Cui

ACS Applied Materials & Interfaces· Volume 16· Issue 35
Publisher page

Abstract

The assessment of biodegradable materials, such as bioactive glass, under the existing ISO 10993 standard test methods poses a significant challenge due to potential cell viability impairment caused by the accumulation of degraded products in a static environment. Therefore, innovative methodologies are urgently needed to tailor the unique biodegradation characteristics of these materials, providing more precise and scientific insights into biosafety and efficacy verification. Motivation by its bidirectional regulation of angiogenesis and immunity, zinc (Zn) was incorporated into sol-gel-derived borosilicate bioactive glasses (SBSGs) to fabricate Zn-incorporated borosilicate bioactive glasses (SBSG-Zn) to complement the tissue repair capabilities of bioactive glasses. Both SBSG and SBSG-Zn glasses consist of nanosized particles, slit mesoporous pores, high specific surface areas, and bioreactivity. In vitro comparative analysis, conducted according to ISO 10993 standards, demonstrates that only at suitable dilution rates─such as the 8-fold dilution employed in this study─do extracts of SBSG and SBSG-Zn glasses exhibit low cytotoxicity when cultured with human umbilical vein endothelial cells (HUVECs). Notably, SBSG-Zn glasses show optimal promotion of angiogenic gene expression in HUVECs. Furthermore, within an appropriate concentration range of released ions, SBSG-Zn glass extracts not only promote cell survival but also modulate the expression of anti-inflammatory genes while simultaneously inhibiting pro-inflammatory genes concurrently. After being implanted in rat subcutaneous defect models, both SBSG and SBSG-Zn glasses demonstrated the local immunoregulation and angiogenic effects. SBSG-Zn stands out by demonstrating superior modulation of M1/M2 polarization in macrophages as validated by altered secretion of key factors in macrophages and expression of relevant growth factors in HUVECs. These findings underscore the potential for convenient manipulation of localized angiogenic and immunoregulation through the incorporation of zinc into bioactive glass, emphasizing the importance of ensuring the appropriate ion doses are applied for achieving optimal therapeutic efficiency.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Tissue Engineering and Regenerative Medicine · Medical and Biological Ozone Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Shenzhen Key Laboratory of Marine Biomedical Materials, CAS-HK Joint Lab of Biomaterials, The Key Laboratory of Biomedical Imaging Science and System, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, Guangdong, P. R. China

Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education and Tianjin, College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, P. R. China

Department of Orthopedics, Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Worker’s Hospital, Liuzhou 545000, Guangxi, P. R. China

Department of Orthopaedics & Traumatology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR 999077, P. R. China

Shenzhen Healthemes Biotechnology Co., Ltd., Shenzhen 518055, Guangdong, P. R. China

Department of Orthopaedics, Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing 400010, P. R. China

Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York 14642, United States

Funding

National Key Research and Development Program of China · Science and Technology Foundation of Shenzhen City · Natural Science Foundation of Chongqing Municipality · Natural Science Foundation of Guangxi Zhuang Autonomous Region · National Natural Science Foundation of China · Shenzhen Medical Research Foundation

References (52)

Show source-provided references
1. 10.1016/j.tibtech.2018.10.00910.1016/j.tibtech.2018.10.009 ↗
2. 10.1007/s12011-013-9658-z10.1007/s12011-013-9658-z ↗
3. 10.1016/j.biomaterials.2010.01.12110.1016/j.biomaterials.2010.01.121 ↗
4. 10.1038/s41598-017-03661-510.1038/s41598-017-03661-5 ↗
5. 10.1002/adma.20200514010.1002/adma.202005140 ↗
6. Yongjiao, C. Clinical study of Pingchuan Mixture Treating Cold Asthmatic Diseases in Children China Medical Guide, 2007: Vol. 28, pp 77–78.
7. 10.1002/advs.20170075510.1002/advs.201700755 ↗
8. 10.1016/j.msec.2017.03.18010.1016/j.msec.2017.03.180 ↗
9. 10.1016/j.mtcomm.2022.10467510.1016/j.mtcomm.2022.104675 ↗
10. 10.1016/S0022-3093(05)80556-310.1016/S0022-3093(05)80556-3 ↗
11. 10.3390/ma1217271110.3390/ma12172711 ↗
12. 10.1002/jbm.82027120410.1002/jbm.820271204 ↗
13. Liu H. · J. Fudan Univ., Nat. Sci. · 2005 · 10 · 87710.1007/BF02832431 ↗
14. GB/T 10993-5 Biological Evaluation of Medical Devices─Part 12: Sample Preparation and Reference Materials, 2004.
15. GB/T 10993-5 Biological Evaluation of Medical Devices─Part 5: Tests for in Vitro Cytotoxicity, 2009.
16. 10.1016/j.apsb.2018.09.00810.1016/j.apsb.2018.09.008 ↗
17. 10.1016/j.jmst.2016.07.00210.1016/j.jmst.2016.07.002 ↗
18. ISO/TS 21726: Biological Evaluation of Medical Devices Application of the Threshold of Toxicological Concern (TTC) for Assessing Biocompatibility of Medical Device Constituents, 2019.
19. 10.1016/j.jnoncrysol.2024.12290910.1016/j.jnoncrysol.2024.122909 ↗
20. 10.1007/s41779-020-00476-y10.1007/s41779-020-00476-y ↗
21. 10.1002/adhm.20230198410.1002/adhm.202301984 ↗
22. 10.1093/rb/rbw00110.1093/rb/rbw001 ↗
23. 10.1016/j.bioactmat.2022.10.02110.1016/j.bioactmat.2022.10.021 ↗
24. 10.1016/j.matchemphys.2012.11.02210.1016/j.matchemphys.2012.11.022 ↗
25. 10.1016/j.pnsc.2015.09.00910.1016/j.pnsc.2015.09.009 ↗
26. 10.1039/c2jm31384g10.1039/c2jm31384g ↗
27. 10.1016/j.jnoncrysol.2009.02.00510.1016/j.jnoncrysol.2009.02.005 ↗
28. 10.1002/jbm.a.1050310.1002/jbm.a.10503 ↗
29. 10.1016/S0272-8842(99)00037-110.1016/S0272-8842(99)00037-1 ↗
30. 10.3390/app1007259510.3390/app10072595 ↗
31. 10.1557/s43578-023-01105-710.1557/s43578-023-01105-7 ↗
32. 10.1016/j.apsusc.2008.06.10110.1016/j.apsusc.2008.06.101 ↗
33. 10.1002/jbm.1002610.1002/jbm.10026 ↗
34. 10.1111/aji.1212910.1111/aji.12129 ↗
35. 10.1002/advs.20190051310.1002/advs.201900513 ↗
36. 10.1007/s12649-023-02147-y10.1007/s12649-023-02147-y ↗
37. 10.1111/iwj.1304110.1111/iwj.13041 ↗
38. 10.1096/fj.201901024RR10.1096/fj.201901024RR ↗
39. Liu K. · J. Prev. Med. Inf. · 2009 · 25 · 715
40. 10.34133/2021/418951610.34133/2021/4189516 ↗
41. 10.1016/j.biomaterials.2021.12103810.1016/j.biomaterials.2021.121038 ↗
42. 10.15252/embj.20179778610.15252/embj.201797786 ↗
43. 10.1038/s41467-022-28203-010.1038/s41467-022-28203-0 ↗
44. 10.1016/j.jep.2015.08.05810.1016/j.jep.2015.08.058 ↗
45. 10.1016/j.alit.2020.11.00110.1016/j.alit.2020.11.001 ↗
46. 10.1002/jbm.a.3158210.1002/jbm.a.31582 ↗
47. 10.1016/j.bioactmat.2019.10.00210.1016/j.bioactmat.2019.10.002 ↗
48. 10.1021/acsami.1c0710310.1021/acsami.1c07103 ↗
49. 10.1159/00032239910.1159/000322399 ↗
50. 10.1016/j.lfs.2023.12159810.1016/j.lfs.2023.121598 ↗
51. 10.1046/j.1365-3164.1998.00074.x10.1046/j.1365-3164.1998.00074.x ↗
52. 10.1007/BF0234478210.1007/BF02344782 ↗